DoD is extending information collections requirements under current OMB Control Number 0720-0032. Pharmaceutical manufacturers will base refund calculation on difference between average non-Federal price of drug sold by pharmaceutical manufacturer to wholesalers, represented by most recent annual non-Federal average manufacturing prices (non-FAMP) and corresponding Federal Ceiling Price (FCP) or, at discretion of pharmaceutical manufacturer, difference between FCP and direct commercial contract sales price attributable to applicable National Drug Code.
The latest form for TRICARE Retail Refunds Request User Account Access expires 2022-10-31 and can be found here.
Document Name |
---|
Supporting Statement A |
Approved without change |
Revision of a currently approved collection | 2022-10-25 | |
Approved without change |
Extension without change of a currently approved collection | 2019-08-29 | |
Approved without change |
Revision of a currently approved collection | 2016-06-06 | |
Approved without change |
Revision of a currently approved collection | 2013-01-31 | |
Approved without change |
Reinstatement with change of a previously approved collection | 2009-11-13 | |
Approved with change |
Revision of a currently approved collection | 2005-11-30 | |
Comment filed on proposed rule and continue |
Revision of a currently approved collection | 2005-03-30 | |
Approved with change |
New collection (Request for a new OMB Control Number) | 2005-03-29 |